NetworkNewsBreaks – Imagin Medical Inc. (CSE: IM
Post# of 31
(Total Views: 167)
Posted On: 04/26/2021 2:42:05 PM
NetworkNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Advancing i/Blue(TM) Imaging Solution
Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, is advancing its proprietary and patented i/Blue(TM) Imaging System. Imagin’s goal is to reduce the cost of treatment for patients with bladder cancer while also improving their chances of survival. Its solution “advances the blue light procedure by allowing surgeons to see the bladder wall under both white and blue light simultaneously in side-by-side presentation, whereas existing systems require surgeons to toggle back and forth between white and blue during the course of the procedure.” According to an article detailing this matter, the existing systems have proven disadvantageous because they increase the likelihood of underestimating the size of the tumor. Fortunately, the i/Blue Imaging System solves this problem. Also, the crucial turning point is imminent as “Imagin is advancing toward manufacturing and FDA approval of its solution.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, is advancing its proprietary and patented i/Blue(TM) Imaging System. Imagin’s goal is to reduce the cost of treatment for patients with bladder cancer while also improving their chances of survival. Its solution “advances the blue light procedure by allowing surgeons to see the bladder wall under both white and blue light simultaneously in side-by-side presentation, whereas existing systems require surgeons to toggle back and forth between white and blue during the course of the procedure.” According to an article detailing this matter, the existing systems have proven disadvantageous because they increase the likelihood of underestimating the size of the tumor. Fortunately, the i/Blue Imaging System solves this problem. Also, the crucial turning point is imminent as “Imagin is advancing toward manufacturing and FDA approval of its solution.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)